News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
244,074 Results
Type
Article (14742)
Company Profile (30)
Press Release (229301)
Section
Business (75380)
Career Advice (724)
Deals (12680)
Drug Delivery (33)
Drug Development (27397)
Employer Resources (20)
FDA (5442)
Job Trends (5276)
News (121505)
Policy (9742)
Tag
Academia (637)
Accelerated approval (14)
Adcomms (4)
Allergies (48)
Alliances (12410)
ALS (53)
Alzheimer's disease (462)
Antibody-drug conjugate (ADC) (123)
Approvals (5662)
Artificial intelligence (93)
Autoimmune disease (65)
Automation (3)
Bankruptcy (103)
Best Places to Work (4116)
BIOSECURE Act (1)
Biosimilars (63)
Biotechnology (25)
Bladder cancer (75)
Brain cancer (25)
Breast cancer (281)
Cancer (1846)
Cardiovascular disease (169)
Career advice (569)
Career pathing (4)
CAR-T (64)
CDC (9)
Cell therapy (188)
Cervical cancer (16)
Clinical research (24574)
Collaboration (380)
Company closure (1)
Compensation (290)
Complete response letters (13)
COVID-19 (711)
CRISPR (22)
C-suite (114)
Cystic fibrosis (32)
Data (2773)
Decentralized trials (1)
Depression (41)
Dermatology (26)
Diabetes (210)
Diagnostics (2088)
Digital health (18)
Diversity (2)
Diversity, equity & inclusion (6)
Drug discovery (59)
Drug pricing (61)
Duchenne muscular dystrophy (63)
Earnings (53173)
Editorial (21)
Employer branding (5)
Employer resources (16)
Events (39261)
Executive appointments (124)
FDA (6581)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (315)
Gene editing (48)
Generative AI (4)
Gene therapy (181)
GLP-1 (382)
Government (1159)
Grass and pollen (1)
Guidances (340)
Healthcare (5553)
HIV (39)
Huntington's disease (27)
IgA nephropathy (25)
Immunology and inflammation (80)
Immuno-oncology (31)
Indications (55)
Infectious disease (825)
Inflammatory bowel disease (66)
Inflation Reduction Act (5)
Influenza (45)
Intellectual property (47)
Interviews (93)
IPO (7168)
IRA (17)
Job creations (1361)
Job search strategy (543)
JPM (15)
Kidney cancer (5)
Labor market (38)
Layoffs (140)
Leadership (5)
Legal (2190)
Liver cancer (29)
Longevity (4)
Lung cancer (278)
Lymphoma (178)
Machine learning (4)
Management (4)
Manufacturing (146)
MASH (70)
Medical device (4327)
Medtech (4356)
Mergers & acquisitions (5842)
Metabolic disorders (529)
mRNA (34)
Multiple sclerosis (48)
NASH (6)
Neurodegenerative disease (117)
Neuropsychiatric disorders (30)
Neuroscience (869)
NextGen: Class of 2026 (1557)
Non-profit (1172)
Now hiring (15)
Obesity (242)
Opinion (57)
Ovarian cancer (75)
Pain (56)
Pancreatic cancer (90)
Parkinson's disease (82)
Partnered (4)
Patents (85)
Patient recruitment (113)
Peanut (14)
People (11656)
Pharmaceutical (8)
Pharmacy benefit managers (7)
Phase 1 (6615)
Phase 2 (10184)
Phase 3 (9344)
Pipeline (3422)
Policy (63)
Postmarket research (1173)
Preclinical (2623)
Press Release (25)
Prostate cancer (79)
Psychedelics (10)
Radiopharmaceuticals (86)
Rare diseases (237)
Real estate (1654)
Recruiting (7)
Regulatory (7707)
Reports (25)
Research institute (555)
Resumes & cover letters (113)
Rett syndrome (15)
RNA editing (6)
RSV (41)
Schizophrenia (64)
Series A (52)
Series B (48)
Sickle cell disease (34)
Special edition (10)
Spinal muscular atrophy (50)
Sponsored (9)
Startups (831)
Stomach cancer (3)
Supply chain (25)
Tariffs (21)
The Weekly (17)
Vaccines (282)
Venture capital (20)
Weight loss (173)
Women's health (22)
Worklife (4)
Date
Today (64)
Last 7 days (270)
Last 30 days (1008)
Last 365 days (10000)
2026 (2447)
2025 (10442)
2024 (11770)
2023 (13130)
2022 (17173)
2021 (17520)
2020 (16450)
2019 (13136)
2018 (9727)
2017 (8680)
2016 (7229)
2015 (8955)
2014 (6897)
2013 (5790)
2012 (38164)
2011 (22663)
2010 (5610)
Location
Africa (273)
Alabama (18)
Arizona (75)
Arkansas (4)
Asia (15155)
Australia (2120)
California (4036)
Canada (1174)
China (396)
Colorado (162)
Connecticut (187)
Delaware (144)
Europe (35077)
Florida (523)
Georgia (119)
Hawaii (1)
Idaho (9)
Illinois (337)
India (16)
Indiana (227)
Iowa (4)
Japan (198)
Kansas (74)
Kentucky (17)
Louisiana (19)
Maine (33)
Maryland (410)
Massachusetts (2785)
Michigan (90)
Minnesota (206)
Mississippi (2)
Missouri (48)
Montana (7)
Nebraska (7)
Nevada (41)
New Hampshire (28)
New Jersey (1443)
New Mexico (3)
New York (1045)
North Carolina (500)
North Dakota (3)
Northern California (2144)
Ohio (82)
Oklahoma (1)
Oregon (4)
Pennsylvania (808)
Puerto Rico (3)
Rhode Island (7)
South America (403)
South Carolina (17)
Southern California (1576)
Tennessee (50)
Texas (618)
United States (14255)
Utah (108)
Virginia (73)
Washington D.C. (15)
Washington State (314)
Wisconsin (26)
244,074 Results for "13".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Atopia Therapeutics Reports Preclinical Proof-of-Concept of Lead Compound ATP-R13 in Atopic Dermatitis and Strengthens Patent Protection
- Preclinical in vivo efficacy data in atopic dermatitis extend previous PoC in allergic asthma - Positive opinion from the European Patent Office strengthens patent protection of ATP-R13 - Progress significantly enhances the strategic attractiveness of ATP-R13 as a broadly applicable, disease-modifying therapy across multiple allergic indications
January 20, 2026
·
1 min read
Press Releases
Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
March 30, 2026
·
2 min read
Press Releases
Correction to Company Announcement No. 13 of March 2, 2026
March 3, 2026
·
3 min read
Press Releases
Medical Engineered Materials Market to Reach USD 99.3 Billion at 13.04% CAGR by 2035
March 31, 2026
·
1 min read
Press Releases
Savara Announces New Employment Inducement Grant - February 13, 2026
February 15, 2026
·
1 min read
Press Releases
4DMT Announces New Employment Inducement Grants - February 13, 2026
February 15, 2026
·
2 min read
Press Releases
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 13, 2026
March 15, 2026
·
1 min read
Press Releases
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 13, 2026
March 15, 2026
·
1 min read
Press Releases
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - March 13, 2026
March 13, 2026
·
1 min read
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat Biosciences’ small-molecule KRAS G12D blocker.
August 12, 2025
·
2 min read
·
Tristan Manalac
1 of 24,408
Next
